Nautilus Biotechnology, Inc. (NAUT) Tops Q1 EPS by 2c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q1 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Jane Street Took $15 Billion Hit In July Tied To Situational Awareness - Reuters